Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Combined HD-tDCS and iTBS in Treating Negative Symptoms of Schizophrenia

NCT07680959 is registered in ClinicalTrials.gov with Tri-Service General Hospital (TSGH) as lead sponsor.

NCT NCT07680959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07680959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Combined HD-tDCS and iTBS in Treating Negative Symptoms of Schizophrenia
Lead sponsor
Tri-Service General Hospital (TSGH)
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
May 6, 2024
Completion date
March 1, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain stimulation intervention, negative symptoms in schizophrenia